B-Cell Infiltrate in the Tumor Microenvironment Is Associated With Improved Survival in Resected Lung Adenocarcinoma

Introduction: Relapse is common after resection of lung adenocarcinoma (LUAD). Features of the tumor microenvironment (TME) which influence postsurgical survival outcomes are poorly characterized. Here, we analyzed the TME of more than 1500 LUAD specimens to identify the relationship between B-cell...

Full description

Bibliographic Details
Main Authors: Ibiayi Dagogo-Jack, MD, Ivan Valiev, MD, Nikita Kotlov, MS, Anna Belozerova, MD, Aleksandra Lopareva, MS, MD, Anna Butusova, MS, Naira Samarina, PhD, Alexandra Boyko, MS, Zhongmin Xiang, PhD, Monique Johnson, BS, Sandrine Degryse, PhD, Florence K. Keane, MD, Lecia V. Sequist, MD, Michael Lanuti, MD, Nathan Fowler, MD, Mari Mino-Kenudson, MD, Alexander Bagaev, PhD
Format: Article
Language:English
Published: Elsevier 2023-07-01
Series:JTO Clinical and Research Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2666364323000668
_version_ 1827893199252750336
author Ibiayi Dagogo-Jack, MD
Ivan Valiev, MD
Nikita Kotlov, MS
Anna Belozerova, MD
Aleksandra Lopareva, MS, MD
Anna Butusova, MS
Naira Samarina, PhD
Alexandra Boyko, MS
Zhongmin Xiang, PhD
Monique Johnson, BS
Sandrine Degryse, PhD
Florence K. Keane, MD
Lecia V. Sequist, MD
Michael Lanuti, MD
Nathan Fowler, MD
Mari Mino-Kenudson, MD
Alexander Bagaev, PhD
author_facet Ibiayi Dagogo-Jack, MD
Ivan Valiev, MD
Nikita Kotlov, MS
Anna Belozerova, MD
Aleksandra Lopareva, MS, MD
Anna Butusova, MS
Naira Samarina, PhD
Alexandra Boyko, MS
Zhongmin Xiang, PhD
Monique Johnson, BS
Sandrine Degryse, PhD
Florence K. Keane, MD
Lecia V. Sequist, MD
Michael Lanuti, MD
Nathan Fowler, MD
Mari Mino-Kenudson, MD
Alexander Bagaev, PhD
author_sort Ibiayi Dagogo-Jack, MD
collection DOAJ
description Introduction: Relapse is common after resection of lung adenocarcinoma (LUAD). Features of the tumor microenvironment (TME) which influence postsurgical survival outcomes are poorly characterized. Here, we analyzed the TME of more than 1500 LUAD specimens to identify the relationship between B-cell infiltration and prognosis. Methods: Whole exome sequencing and bulk RNA sequencing were performed on LUADs and adjacent normal lung tissue. Relapse-free survival and overall survival (OS) were retrospectively correlated with characteristics of the tumor and TME in three data sets. Results: High B-cell content (defined as >10% B cells) was associated with improved OS in both a The Cancer Genome Atlas–resected LUAD data set (p = 0.01) and a separate institutional stage II LUAD data set (p = 0.04, median not reached versus 89.5 mo). A validation cohort consisting of pooled microarray data representing more than 1400 resected stage I to III LUADs confirmed the association between greater B-cell abundance, specifically higher B-cell expression, and longer postsurgical survival (median OS 90 versus 71 mo, p < 0.01). Relapse-free survival was longer for patients with adenocarcinomas with high B-cell content across data sets, but it did not reach statistical significance. Subcategorization of B-cell subsets indicated that high naive B-cell content was most predictive of survival. There was no correlation between programmed death-ligand 1 expression, lymphoid aggregates, or overall immune infiltrate density and survival outcomes across the cohorts. Conclusions: The growing adjuvant immunotherapy repertoire has increased the urgency for identifying prognostic and predictive biomarkers. Comprehensive profiling of more than 1500 LUADs suggests that high tumor-infiltrating B-cell content is a favorable prognostic marker.
first_indexed 2024-03-12T21:50:26Z
format Article
id doaj.art-acbc54d5c39b41eeb5768d2ee56dbc4c
institution Directory Open Access Journal
issn 2666-3643
language English
last_indexed 2024-03-12T21:50:26Z
publishDate 2023-07-01
publisher Elsevier
record_format Article
series JTO Clinical and Research Reports
spelling doaj.art-acbc54d5c39b41eeb5768d2ee56dbc4c2023-07-26T04:09:39ZengElsevierJTO Clinical and Research Reports2666-36432023-07-0147100527B-Cell Infiltrate in the Tumor Microenvironment Is Associated With Improved Survival in Resected Lung AdenocarcinomaIbiayi Dagogo-Jack, MD0Ivan Valiev, MD1Nikita Kotlov, MS2Anna Belozerova, MD3Aleksandra Lopareva, MS, MD4Anna Butusova, MS5Naira Samarina, PhD6Alexandra Boyko, MS7Zhongmin Xiang, PhD8Monique Johnson, BS9Sandrine Degryse, PhD10Florence K. Keane, MD11Lecia V. Sequist, MD12Michael Lanuti, MD13Nathan Fowler, MD14Mari Mino-Kenudson, MD15Alexander Bagaev, PhD16Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts; Corresponding author. Address for correspondence: Ibiayi Dagogo-Jack, MD, Department of Thoracic Oncology, Massachusetts General Hospital Cancer Center, 32 Fruit Street, Yawkey 7B Boston, MA 02114.BostonGene Corporation, Waltham, MassachusettsBostonGene Corporation, Waltham, MassachusettsBostonGene Corporation, Waltham, MassachusettsBostonGene Corporation, Waltham, MassachusettsBostonGene Corporation, Waltham, MassachusettsBostonGene Corporation, Waltham, MassachusettsBostonGene Corporation, Waltham, MassachusettsBostonGene Corporation, Waltham, MassachusettsBostonGene Corporation, Waltham, MassachusettsBostonGene Corporation, Waltham, MassachusettsHarvard Medical School, Boston, MassachusettsHarvard Medical School, Boston, MassachusettsHarvard Medical School, Boston, MassachusettsBostonGene Corporation, Waltham, MassachusettsHarvard Medical School, Boston, MassachusettsBostonGene Corporation, Waltham, MassachusettsIntroduction: Relapse is common after resection of lung adenocarcinoma (LUAD). Features of the tumor microenvironment (TME) which influence postsurgical survival outcomes are poorly characterized. Here, we analyzed the TME of more than 1500 LUAD specimens to identify the relationship between B-cell infiltration and prognosis. Methods: Whole exome sequencing and bulk RNA sequencing were performed on LUADs and adjacent normal lung tissue. Relapse-free survival and overall survival (OS) were retrospectively correlated with characteristics of the tumor and TME in three data sets. Results: High B-cell content (defined as >10% B cells) was associated with improved OS in both a The Cancer Genome Atlas–resected LUAD data set (p = 0.01) and a separate institutional stage II LUAD data set (p = 0.04, median not reached versus 89.5 mo). A validation cohort consisting of pooled microarray data representing more than 1400 resected stage I to III LUADs confirmed the association between greater B-cell abundance, specifically higher B-cell expression, and longer postsurgical survival (median OS 90 versus 71 mo, p < 0.01). Relapse-free survival was longer for patients with adenocarcinomas with high B-cell content across data sets, but it did not reach statistical significance. Subcategorization of B-cell subsets indicated that high naive B-cell content was most predictive of survival. There was no correlation between programmed death-ligand 1 expression, lymphoid aggregates, or overall immune infiltrate density and survival outcomes across the cohorts. Conclusions: The growing adjuvant immunotherapy repertoire has increased the urgency for identifying prognostic and predictive biomarkers. Comprehensive profiling of more than 1500 LUADs suggests that high tumor-infiltrating B-cell content is a favorable prognostic marker.http://www.sciencedirect.com/science/article/pii/S2666364323000668B cellsresectedlung cancertumor microenvironment
spellingShingle Ibiayi Dagogo-Jack, MD
Ivan Valiev, MD
Nikita Kotlov, MS
Anna Belozerova, MD
Aleksandra Lopareva, MS, MD
Anna Butusova, MS
Naira Samarina, PhD
Alexandra Boyko, MS
Zhongmin Xiang, PhD
Monique Johnson, BS
Sandrine Degryse, PhD
Florence K. Keane, MD
Lecia V. Sequist, MD
Michael Lanuti, MD
Nathan Fowler, MD
Mari Mino-Kenudson, MD
Alexander Bagaev, PhD
B-Cell Infiltrate in the Tumor Microenvironment Is Associated With Improved Survival in Resected Lung Adenocarcinoma
JTO Clinical and Research Reports
B cells
resected
lung cancer
tumor microenvironment
title B-Cell Infiltrate in the Tumor Microenvironment Is Associated With Improved Survival in Resected Lung Adenocarcinoma
title_full B-Cell Infiltrate in the Tumor Microenvironment Is Associated With Improved Survival in Resected Lung Adenocarcinoma
title_fullStr B-Cell Infiltrate in the Tumor Microenvironment Is Associated With Improved Survival in Resected Lung Adenocarcinoma
title_full_unstemmed B-Cell Infiltrate in the Tumor Microenvironment Is Associated With Improved Survival in Resected Lung Adenocarcinoma
title_short B-Cell Infiltrate in the Tumor Microenvironment Is Associated With Improved Survival in Resected Lung Adenocarcinoma
title_sort b cell infiltrate in the tumor microenvironment is associated with improved survival in resected lung adenocarcinoma
topic B cells
resected
lung cancer
tumor microenvironment
url http://www.sciencedirect.com/science/article/pii/S2666364323000668
work_keys_str_mv AT ibiayidagogojackmd bcellinfiltrateinthetumormicroenvironmentisassociatedwithimprovedsurvivalinresectedlungadenocarcinoma
AT ivanvalievmd bcellinfiltrateinthetumormicroenvironmentisassociatedwithimprovedsurvivalinresectedlungadenocarcinoma
AT nikitakotlovms bcellinfiltrateinthetumormicroenvironmentisassociatedwithimprovedsurvivalinresectedlungadenocarcinoma
AT annabelozerovamd bcellinfiltrateinthetumormicroenvironmentisassociatedwithimprovedsurvivalinresectedlungadenocarcinoma
AT aleksandraloparevamsmd bcellinfiltrateinthetumormicroenvironmentisassociatedwithimprovedsurvivalinresectedlungadenocarcinoma
AT annabutusovams bcellinfiltrateinthetumormicroenvironmentisassociatedwithimprovedsurvivalinresectedlungadenocarcinoma
AT nairasamarinaphd bcellinfiltrateinthetumormicroenvironmentisassociatedwithimprovedsurvivalinresectedlungadenocarcinoma
AT alexandraboykoms bcellinfiltrateinthetumormicroenvironmentisassociatedwithimprovedsurvivalinresectedlungadenocarcinoma
AT zhongminxiangphd bcellinfiltrateinthetumormicroenvironmentisassociatedwithimprovedsurvivalinresectedlungadenocarcinoma
AT moniquejohnsonbs bcellinfiltrateinthetumormicroenvironmentisassociatedwithimprovedsurvivalinresectedlungadenocarcinoma
AT sandrinedegrysephd bcellinfiltrateinthetumormicroenvironmentisassociatedwithimprovedsurvivalinresectedlungadenocarcinoma
AT florencekkeanemd bcellinfiltrateinthetumormicroenvironmentisassociatedwithimprovedsurvivalinresectedlungadenocarcinoma
AT leciavsequistmd bcellinfiltrateinthetumormicroenvironmentisassociatedwithimprovedsurvivalinresectedlungadenocarcinoma
AT michaellanutimd bcellinfiltrateinthetumormicroenvironmentisassociatedwithimprovedsurvivalinresectedlungadenocarcinoma
AT nathanfowlermd bcellinfiltrateinthetumormicroenvironmentisassociatedwithimprovedsurvivalinresectedlungadenocarcinoma
AT mariminokenudsonmd bcellinfiltrateinthetumormicroenvironmentisassociatedwithimprovedsurvivalinresectedlungadenocarcinoma
AT alexanderbagaevphd bcellinfiltrateinthetumormicroenvironmentisassociatedwithimprovedsurvivalinresectedlungadenocarcinoma